FABIAN 2008

The FABIAN 2008 program is as follows:

09:30	Registration & coffee

10:00	Welcome & Opening Jaap Wieling FABIAN-board, Xendo Drug Development

10:05	Biosimilars or why proteins cannot be copied Vera Brinks Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht, the Netherlands
08L01
10:50	Comparability Assessment Strategies and Techniques for Post-Approval CMC Changes Reed Harris Protein Analytical Chemistry, Genentech Inc. South San Francisco, CA, USA
08L02
11:35	Development of Biosimilars: Binocrit® - the worlds first biosimilar ESA as a case study Andreas Seidl, Uwe Demelbauer, Carsten Brockmeyer Sandoz Biopharmaceutical Development, Hexal AG, Oberhaching, Germany
08L03
12:20	Lunch, postersessie

13:15	Analytical assessment of biotech product quality Robert van den Heuvel Schering-Plough, Oss
08L04
13:55	Oral recombinant enzyme replacement therapy: DMPK and Immunogenicity Assessment (A Case Study) Claudia Berger Solvay Pharmaceuticals, Hanover, Germany SPEAKER ILL: WITHDRAWN
08L05
14:35	THE CHALLENGES OF “LARGE MOLECULE” LIGAND-BINDING ASSAYS - VALIDATION AND BIOANALYSIS Joseph Marini Centocor, Radnor, PA, USA
08L06
15:15	Immunogenicity considerations for biologics Meena Subramanyan Biogen Idec, Cambridge, MA, USA
08L07
16.00	Sluiting & Borrel

* Contact

[ Programma ] [ Abstracts ] [ Posters ] [ Submissie ] [ Slides ] [ Hotels ] [ Route ]
[ 2001 ] [ 2002 ] [ 2003 ] [ 2004 ] [ 2005 ] [ 2006 ] [ 2007 ] [ 2008 ] [ 2009 ]

Last update
27-Oct-09